Have a feature idea you'd love to see implemented?
Let us know!
TFFP TFF Pharmaceuticals Inc
Price (delayed)
$1.88
Market cap
$6.52M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$7.47
Enterprise value
$2.2M
TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms
Highlights
The EPS has soared by 59% year-on-year and by 23% since the previous quarter
The revenue has soared by 53% year-on-year and by 36% since the previous quarter
TFF Pharmaceuticals's quick ratio has shrunk by 81% YoY but it has increased by 46% QoQ
The equity has dropped by 52% year-on-year but it is up by 11% since the previous quarter
Key stats
What are the main financial stats of TFFP
Market
Valuations
Earnings
Shares outstanding
3.47M
Market cap
$6.52M
Enterprise value
$2.2M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.99
Price to sales (P/S)
5.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.83
Revenue
$1.2M
EBIT
-$19.39M
EBITDA
-$18.85M
Free cash flow
-$13.67M
Per share
Balance sheet
Liquidity
EPS
-$7.47
Free cash flow per share
-$3.73
Book value per share
$1.9
Revenue per share
$0.33
TBVPS
$2.59
Total assets
$9.5M
Total liabilities
$3.62M
Debt
$74,124
Equity
$5.88M
Working capital
$2.26M
Debt to equity
0.01
Current ratio
1.63
Quick ratio
1.21
Net debt/EBITDA
0.23
Margins
Efficiency
Dividend
EBITDA margin
-1,567.4%
Gross margin
100%
Net margin
-1,612%
Operating margin
-1,625.1%
Return on assets
-170.1%
Return on equity
-225.2%
Return on invested capital
-638.2%
Return on capital employed
-329.8%
Return on sales
-1,612%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TFFP stock price
How has the TFF Pharmaceuticals stock price performed over time
Intraday
-6.47%
1 week
-0.53%
1 month
-3.59%
1 year
-78.37%
YTD
-73.22%
QTD
-6.47%
Financial performance
How have TFF Pharmaceuticals's revenue and profit performed over time
Revenue
$1.2M
Gross profit
$1.2M
Operating income
-$19.54M
Net income
-$19.39M
Gross margin
100%
Net margin
-1,612%
The net margin has soared by 53% YoY and by 28% from the previous quarter
The revenue has soared by 53% year-on-year and by 36% since the previous quarter
TFF Pharmaceuticals's gross profit has soared by 53% YoY and by 36% from the previous quarter
The operating margin has soared by 52% YoY and by 30% from the previous quarter
Growth
What is TFF Pharmaceuticals's growth rate over time
Valuation
What is TFF Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.99
P/S
5.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.83
The EPS has soared by 59% year-on-year and by 23% since the previous quarter
TFFP's price to book (P/B) is 75% lower than its 5-year quarterly average of 3.9 and 38% lower than its last 4 quarters average of 1.6
The equity has dropped by 52% year-on-year but it is up by 11% since the previous quarter
The stock's price to sales (P/S) is 59% less than its last 4 quarters average of 14.1
The revenue has soared by 53% year-on-year and by 36% since the previous quarter
Efficiency
How efficient is TFF Pharmaceuticals business performance
The ROS has soared by 53% year-on-year and by 28% since the previous quarter
The return on equity has declined by 47% year-on-year and by 15% since the previous quarter
The ROIC has declined by 27% year-on-year and by 24% since the previous quarter
TFF Pharmaceuticals's return on assets has decreased by 21% YoY and by 6% QoQ
Dividends
What is TFFP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TFFP.
Financial health
How did TFF Pharmaceuticals financials performed over time
The total assets is 162% more than the total liabilities
The total liabilities has soared by 181% YoY but it has contracted by 7% from the previous quarter
TFF Pharmaceuticals's quick ratio has shrunk by 81% YoY but it has increased by 46% QoQ
The debt is 99% less than the equity
The debt has plunged by 52% YoY and by 22% from the previous quarter
The equity has dropped by 52% year-on-year but it is up by 11% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.